Abstract:Cancer immunotherapy is a treatment method that activates or enhances the autoimmune response of the body to fight tumor growth and metastasis, has fewer toxic side effects and a longer-lasting efficacy than radiotherapy and chemotherapy, and has become an important means for the clinical treatment of cancer. However, clinical results from immunotherapy have shown that most patients lack responsiveness to immunotherapy and cannot benefit from this treatment strategy. The tumor microenvironment (TME) plays a critical role in the response to immunotherapy. The TME typically prevents effective lymphocyte activation, reducing their infiltration, and inhibiting the infiltration of effector T cells. According to the characteristic differences between the TME and normal tissues, various nanoplatforms with TME targeting and regulation properties have been developed for more precise regulation of the TME and have the ability to codeliver a variety of active pharmaceutical ingredients, thereby reducing systemic toxicity and improving the therapeutic effect of antitumor. In addition, the precise structural design of the nanoplatform can integrate specific functional motifs, such as surface-targeted ligands, degradable backbones, and TME stimulus-responsive components, into nanomedicines, thereby reshaping the tumor microenvironment, improving the body's immunosuppressive state, and enhancing the permeability of drugs in tumor tissues, in order to achieve controlled and stimulus-triggered release of load cargo. In this review, the physiological characteristics of the TME and the latest research regarding the application of TME-regulated nanoplatforms in improving antitumor immunotherapy will be described. Furthermore, the existing problems and further applications perspectives of TME-regulated platforms for cancer immunotherapy will also be discussed.

Bioinspired Membrane-Coated Nanoplatform for Targeted Tumor Immunotherapy

Membrane-Coated Biomimetic Nanoparticles: A State-of-the-Art Multifunctional Weapon for Tumor Immunotherapy

Recent Progress of Bioinspired Cell Membrane in Cancer Immunotherapy

Immunocyte Membrane-Derived Biomimetic Nano-Drug Delivery System: a Pioneering Platform for Tumour Immunotherapy

Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy

Nanoengineered Targeting Strategy for Cancer Immunotherapy

Advances in Nanoplatforms for Immunotherapy Applications Targeting the Tumor Microenvironment

Improving Cancer Immunotherapy by Cell Membrane‐Camouflaged Nanoparticles

Research Progress of Cell Membrane Biomimetic Nanoparticles for Tumor Therapy

Biomimetic Cell Membrane‐Coated Nanoparticles for Cancer Theranostics

Biomembrane nanostructures: Multifunctional platform to enhance tumor chemoimmunotherapy via effective drug delivery

Cancer cell membrane–encapsulated biomimetic nanoparticles for tumor immuno-photothermal therapy

Cancer cell membrane-wrapped nanoparticles for cancer immunotherapy: A review of current developments

Cell Membrane-Based Nanoparticles: a New Biomimetic Platform for Tumor Diagnosis and Treatment

Application of Cell Membrane-Coated Nanomaterials for Tumor Treatment.

Membrane-coated nanoparticles as a biomimetic targeted delivery system for tumour therapy

Cell Membrane-Coated Nanoparticles for Tumor-Targeted Drug Delivery

Cell Membrane-Coated Biomimetic Nanoparticles in Cancer Treatment

Intelligent Nanoplatform Integrating Macrophage and Cancer Cell Membrane for Synergistic Chemodynamic/Immunotherapy/Photothermal Therapy of Breast Cancer

Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics

Advances in Targeted Nanotherapeutics: from Bioconjugation to Biomimicry